DIA Europe 2019 has ended
Back To Schedule
Wednesday, February 6 • 15:15 - 16:15
#S0103: The Regulatory Role in EU Public-Private Partnerships (PPPs)

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Session

This forum will discuss how regulatory contribution to EU public-private partnerships like the Innovative Medicines Initiative (IMI) was critical for its outcomes and for the advancement of EU regulatory science. Panelists will reflect on past and current achievements, while looking beyond 2019 and towards the new Framework Programme 9 (Horizon Europe), reflecting on possible partnerships that can bring added value to drug development and healthcare in the EU and globally.


João Duarte, MPharm, MSc


Panel Discussion
Magda Chlebus, MA

Panel Discussion
Solange Corriol-Rohou, DrMed, MD, PhD

Panel Discussion
David Haerry

avatar for João Duarte

João Duarte

Director, Business Planning & Operations, Global Regulatory Affairs, R&D and Com, Alexion, Astrazeneca Rare Disease, France
João Duarte is currently Director, Business Planning & Operations at Alexion, AstraZenenca Rare Disease. João serves as Chief of Staff to the Head of Regulatory & Quality Affairs and leads regulatory policy activities within the team. He held several roles since 2012 in Regulatory... Read More →

Magda Chlebus

Executive Director Science Policy & Regulatory Affairs, EFPIA
Magda Chlebus is Executive Director Science Policy & Regulatory Affairs at the European Federation of Pharmaceutical Industries and Associations (EFPIA), representing the R&D-based pharmaceutical industry in Europe.Magda and her team are in charge of following policy and legislative... Read More →
avatar for Solange Corriol-Rohou

Solange Corriol-Rohou

Senior Director, Global Regulatory Affairs & Policy, R&D, Europe, AstraZeneca
Pulmonologist and immuno-allergist by training, Solange joined AstraZeneca R&D in 2004 and is currently Sr. Global Policy Director, with responsibilities in the Respiratory/Infection and Vaccine/Immune therapies franchise. Over the past 20 years, moving from the French Medicines Agency/EMA... Read More →
avatar for David Haerry

David Haerry

Member, European AIDS Treatment Group
David has been involved with health care professionals’ education projects since 2007 and, in 2015, became Secretary General for the Swiss Academic Foundation on Education in Infectious Diseases (SAFE-ID). He has been Work-Package Co-leader and a member of the Executive Committee... Read More →

Wednesday February 6, 2019 15:15 - 16:15 CET
E1 Austria Center Vienna Bruno-Kreisky-Platz 1 1220 Vienna Austria
  01 Stakeholders and Regulatory System Optimisation, Session
  • Featured Topics Regulatory Science
  • Tags Session